QUALIGEN THERAPEUTICS INC (QLGNXXXX)
Institutional ownership reported to the SEC as of Q3 2024, across 18 quarters.
17
Reporting holders
$90.8K
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| UBS Group AG | $35.0K | 204,509 | 0.00% | 2q | +194.2%+$23.1K |
| CITADEL ADVISORS LLC | $26.2K | 153,607 | 0.00% | new | NEW |
| GEODE CAPITAL MANAGEMENT, LLC | $7.8K | 45,759 | 0.00% | 8q | +51.4%+$2.6K |
| BlackRock, Inc. | $4.4K | 25,607 | 0.00% | new | FIRST |
| VANGUARD GROUP INC | $3.9K | 22,827 | 0.00% | 5q | HELD |
| XTX Topco Ltd | $3.4K | 19,872 | 0.00% | 3q | -14.1% |
| Cresset Asset Management, LLC | $2.7K | 16,000 | 0.00% | 2q | HELD |
| NORTHERN TRUST CORP | $2.0K | 11,899 | 0.00% | 5q | HELD |
| STATE STREET CORP | $1.9K | 10,930 | 0.00% | 8q | HELD |
| Jump Financial, LLC | $1.7K | 10,164 | 0.00% | new | NEW |
| HighMark Wealth Management LLC | $1.4K | 8,009 | 0.00% | 8q | HELD |
| BANK OF AMERICA CORP /DE/ | $159 | 933 | 0.00% | 4q | +1694.2% |
| US BANCORP \DE\ | $140 | 824 | 0.00% | 8q | HELD |
| JPMORGAN CHASE & CO | $86 | 504 | 0.00% | 6q | HELD |
| GROUP ONE TRADING LLC | $72 | 423 | 0.00% | 8q | HELD |
| HRT FINANCIAL LP | $16 | 97,798 | 0.00% | 3q | +58.9% |
| SIGNATUREFD, LLC | $3 | 20 | 0.00% | new | NEW |
| Archer Investment Corp | $3 | 16 | 0.00% | 8q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2024 | 17 | $90.8K | 531,903 | 3 | 3 | 1 | 0.0% |
| Q2 2024 | 17 | $53.3K | 309,293 | 3 | 3 | 2 | 0.0% |
| Q1 2024 | 16 | $77.8K | 197,539 | 1 | 3 | 3 | 0.0% |
| Q4 2023 | 18 | $90.8K | 165,066 | 5 | 3 | 0 | 0.0% |
| Q3 2023 | 13 | $129.3K | 128,064 | 2 | 4 | 1 | 0.0% |
| Q2 2023 | 14 | $69.0K | 75,701 | 3 | 2 | 2 | 0.0% |
| Q1 2023 | 10 | $73.9K | 79,922 | 0 | 3 | 2 | 0.0% |
| Q4 2022 | 11 | $186.6K | 144,580 | 11 | 0 | 0 | 0.0% |
| Q3 2022 | 24 | $630.0K | 2,320,648 | 2 | 4 | 0 | 1.4% |
| Q2 2022 | 25 | $1.4M | 2,274,870 | 1 | 3 | 7 | 4.4% |
| Q1 2022 | 30 | $1.9M | 2,808,708 | 8 | 2 | 4 | 2.5% |
| Q4 2021 | 29 | $3.2M | 2,750,989 | 6 | 4 | 9 | 9.1% |
| Q3 2021 | 27 | $3.7M | 2,778,239 | 4 | 5 | 4 | 1.3% |
| Q2 2021 | 28 | $5.2M | 2,534,934 | 3 | 7 | 5 | 3.0% |
| Q1 2021 | 29 | $7.2M | 1,893,702 | 8 | 7 | 1 | 28.6% |
| Q4 2020 | 26 | $6.1M | 1,190,365 | 12 | 6 | 3 | 40.9% |
| Q3 2020 | 15 | $4.0M | 810,100 | 10 | 3 | 1 | 0.0% |
| Q2 2020 | 9 | $17.3M | 110,857 | 9 | 0 | 0 | 97.5% |